Show simple item record

dc.contributor.authorChacón García, Antonio J.
dc.contributor.authorRojas Macías, Sara 
dc.contributor.authorGrape, Erik Svensson
dc.contributor.authorSalles, Fabrice
dc.contributor.authorWillhammar, Tom
dc.contributor.authorInge, A. Ken
dc.contributor.authorPérez, Yolanda
dc.contributor.authorHorcajada, Patricia
dc.date.accessioned2024-09-05T07:57:43Z
dc.date.available2024-09-05T07:57:43Z
dc.date.issued2024-04-03
dc.identifier.citationChacón-García, A.J., Rojas, S., Grape, E.S. et al. SU-101 for the removal of pharmaceutical active compounds by the combination of adsorption/photocatalytic processes. Sci Rep 14, 7882 (2024). https://doi.org/10.1038/s41598-024-58014-wes_ES
dc.identifier.urihttps://hdl.handle.net/10481/93970
dc.description.abstractPharmaceutical active compounds (PhACs) are some of the most recalcitrant water pollutants causing undesired environmental and human effects. In absence of adapted decontamination technologies, there is an urgent need to develop efficient and sustainable alternatives for water remediation. Metal–organic frameworks (MOFs) have recently emerged as promising candidates for adsorbing contaminants as well as providing photoactive sites, as they possess exceptional porosity and chemical versatility. To date, the reported studies using MOFs in water remediation have been mainly focused on the removal of a single type of PhACs and rarely on the combined elimination of PhACs mixtures. Herein, the eco-friendly bismuth-based MOF, SU-101, has been originally proposed as an efficient adsorbent-photocatalyst for the elimination of a mixture of three challenging persistent PhACs, frequently detected in wastewater and surface water in ng L−1 to mg·L−1 concentrations: the antibiotic sulfamethazine (SMT), the anti-inflammatory diclofenac (DCF), and the antihypertensive atenolol (At). Adsorption experiments of the mixture revealed that SU-101 exhibited a great adsorption capacity towards At, resulting in an almost complete removal (94.1 ± 0.8% for combined adsorption) in only 5 h. Also, SU-101 demonstrated a remarkable photocatalytic activity under visible light to simultaneously degrade DCF and SMT (99.6 ± 0.4% and 89.2 ± 1.4%, respectively). In addition, MOF-contaminant interactions, the photocatalytic mechanism and degradation pathways were investigated, also assessing the toxicity of the resulting degradation products. Even further, recycling and regeneration studies were performed, demonstrating its efficient reuse for 4 consecutive cycles without further treatment, and its subsequent successful regeneration by simply washing the material with a NaCl solution.es_ES
dc.description.sponsorshipMOFSEIDON project PID2019-104228RB-100, MCI/AEI/FEDER, UEes_ES
dc.description.sponsorshipGrant (RYC2021‐032522‐I) funded by MCIN/AEI/https://doi.org/10.13039/501100011033 and for El FSE invierte en tu futurees_ES
dc.description.sponsorshipSwedish Foundation of Strategic Research (SSF)es_ES
dc.description.sponsorshipFormas—a Swedish Research Council for Sustainable Development (FORMAS, 2022-01270)es_ES
dc.language.isoenges_ES
dc.publisherSpringer Naturees_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectSU-101es_ES
dc.subjectPhotoactive Bi-MOFes_ES
dc.subjectPharmaceutical active compoundses_ES
dc.titleSU‑101 for the removal of pharmaceutical active compounds by the combination of adsorption/photocatalytic processeses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1038/s41598-024-58014-w
dc.type.hasVersionVoRes_ES


Files in this item

[PDF]

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
Except where otherwise noted, this item's license is described as Atribución 4.0 Internacional